Triple Boost Eye Bright

Triple Boost Eye Bright uses a synergy of treatments, including dermal fillers, mesotherapy and PRP, to freshen and brighten the delicate skin around the eyes.

HYALURONIC ACID dermal fillers to hydrate, restore volume and enhance facial contouring

MESOTHERAPY to stimulate collagen and elastin production

PRP to naturally soften fine lines, wrinkles and dark circles whilst improving skin texture and tone

WHAT TO EXPECT?

The patient’s face is anaesthetized before hyaluronic acid is injected at certain points around the eye. Once the filler is administered, the patient’s own centrifuged blood is prepared by separating the plasma. This platelet rich plasma is then injected both deeply and superficially into the skin and gently massaged in the periorbital area. Following PRP, a series of microinjections packed with active ingredients such as vitamins, minerals and essential amino acids are injected into the skin to help boost collagen production, hydrate skin and restore firmness. Downtime is short-lived; effects of Mesotherapy, PRP and Hyaluronic acid fillers will include swelling, redness, ecchymosis (bruising of the skin) and slight discomfort that comes with any injection. These reactions are generally mild to moderate and usually resolve within a few days.

WHAT ARE THE BENEFITS OF TRIPLE BOOST EYE BRIGHT?

The Triple Boost Hydrabright is a great treatment option to rejuvenate skin without resorting to more invasive surgery, helping to define the contours and restore lost volume to your face with noticeable but natural-looking results. Improvement of skin texture and tone are generally noticeable within three weeks but full collagen regeneration can take up to three months. Although you may see a change after your first treatment, you may require a series of sessions to obtain optimum results. The results of PRP, Fillers and Mesotherapy are not permanent, as a natural degradation will occur over time, but improvements can last up to a year.
This treatment can be used on the entire face.